297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC

作者：Suresh Senan, Ying Cheng, D.R. Spigel, Byoung Chul Cho, K. Laktionov, Y. Zenke, Ki Hyeong Lee, A.F. Navarro Mendivil, Isamu Okamoto, Sema Sezgin Göksu, A. Badzio, Aiping Shi, Milada Zemanová, N. Reinmuth, P. Iyengar, L. Paz-Ares, Jie Chen, W.C.V. Lai, P. Chugh, Yuanbin Chen · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/s1556-0864(25)00489-7 · 被引用次数：6 · 研究领域：Lung Cancer Research Studies、Peptidase Inhibition and Analysis、Cancer therapeutics and mechanisms